How Weight-Loss Drugs Could Reshape the Landscape of Addiction Treatment

About this episode

Sylvie Stacy, MD, MPH, discusses the potential of GLP-1s in treating substance use disorders.

Sylvie Stacy, MD, MPH, joins Over the Counter to discuss the emerging evidence regarding GLP-1s for various types of substance use disorders and the potential role this medication class can play for millions of vulnerable patients.

People in this episode

Host: Over the Counter

Guest: Sylvie Stacy, MD, MPH

Topics covered

• weight-loss drugs
• addiction treatment
• substance use disorders
• GLP-1 medications
• healthcare
• vulnerable patients

Keywords

• weight-loss drugs
• addiction treatment
• GLP-1
• substance use disorders
• healthcare
• vulnerable patients

Mentioned in this episode

Organizations: Over the Counter, Drug Topics

Products: GLP-1s

More episodes of Over the Counter

• NCPDP Standards Advance Pharmacy Interoperability, AI, and Drug Access · June 11, 2026 · 15 min
• Why Pharmacists Play an Integral Role in Team-Based Diabetes Care · June 4, 2026 · 16 min
• The Pharmacist’s Role in Bridging Menopause Care Gaps · May 28, 2026 · 14 min
• Independent Pharmacy’s Adaptability Through Reform, Closures, and Technology · May 21, 2026 · 20 min
• Pharmacists Are Essential in Advancing Modern Approaches to Diabetes Care · May 14, 2026 · 25 min
• The Pharmacy Rewards Program Improving Outcomes Through Key Partnerships · May 7, 2026 · 20 min